Eric Benevich - Dec 10, 2024 Form 3 Insider Report for aTYR PHARMA INC (ATYR)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Stock symbol
ATYR
Transactions as of
Dec 10, 2024
Transactions value $
$0
Form type
3
Date filed
12/12/2024, 04:12 PM
Previous filing
Apr 17, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.